BioNTech SE (BioNTech SE) Days Payable : 145.70 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is BioNTech SE Days Payable?

BioNTech SE's average Accounts Payable for the three months ended in Dec. 2023 was $312 Mil. BioNTech SE's Cost of Goods Sold for the three months ended in Dec. 2023 was $195 Mil. Hence, BioNTech SE's Days Payable for the three months ended in Dec. 2023 was 145.70.

The historical rank and industry rank for BioNTech SE's Days Payable or its related term are showing as below:

BNTX' s Days Payable Range Over the Past 10 Years
Min: 16.93 Med: 372.46 Max: 1284.69
Current: 126.27

During the past 8 years, BioNTech SE's highest Days Payable was 1284.69. The lowest was 16.93. And the median was 372.46.

BNTX's Days Payable is ranked worse than
53.84% of 717 companies
in the Biotechnology industry
Industry Median: 153.86 vs BNTX: 126.27

BioNTech SE's Days Payable increased from Dec. 2022 (119.65) to Dec. 2023 (145.70). It may suggest that BioNTech SE delayed paying its suppliers.

BioNTech SE Days Payable Historical Data

The historical data trend for BioNTech SE's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Days Payable Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

663.02

372.46

16.93

22.84

168.04

BioNTech SE Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															119.65	110.18	72.30	128.24	145.70

Competitive Comparison of BioNTech SE's Days Payable

For the Biotechnology subindustry, BioNTech SE's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioNTech SE's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioNTech SE's Days Payable distribution charts can be found below:

* The bar in red indicates where BioNTech SE's Days Payable falls into.

BioNTech SE Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

BioNTech SE's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (216.208	+	386.041)	/	2 )	/	654.089	*	365
=	301.1245					/	654.089	*	365
=	168.04

BioNTech SE's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (237.673	+	386.041)	/	2 )	/	195.311	*	365 / 4
=	311.857					/	195.311	*	365 / 4
=	145.70

BioNTech SE Days Payable Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE (BioNTech SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (NAS:BNTX) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil BNTX:Austria

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.